Clinical trial
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of…
NCT00143884 · University of Michigan Rogel Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00143884 |
|---|---|
| Title | Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood |
| Official title | Adjuvant Cellular Immunotherapy for High-Risk Hematologic Malignancy After Allogeneic Stem Cell Transplantation Using Low Intensity Conditioning |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Low-Grade, Non-Hodgkin's, Multiple Myeloma, Myelodysplastic Syndromes |
| Intervention type | Procedure |
| Interventions | Reduced intensity conditioning, Prophylactic donor leukocyte infusions |
| Enrollment | 30 |
| Start date | Mar 1, 2000 |
| First posted | Sep 2, 2005 |
| Last update posted | Apr 23, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: